|
RAD1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.99720000000547E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.215200E-03 |
| Normal-vs-Stage2 |
3.882000E-02 |
| Normal-vs-Stage3 |
3.60620000000589E-05 |
| Normal-vs-Stage4 |
3.227600E-04 |
| Stage1-vs-Stage2 |
7.772200E-01 |
| Stage1-vs-Stage3 |
3.949700E-02 |
| Stage1-vs-Stage4 |
1.275040E-01 |
| Stage2-vs-Stage3 |
4.261800E-01 |
| Stage2-vs-Stage4 |
5.427600E-01 |
| Stage3-vs-Stage4 |
8.287000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.33749999999966E-05 |
| Normal-vs-AfricanAmerican |
1.87721000000085E-05 |
| Normal-vs-Asian |
4.767400E-01 |
| Caucasian-vs-AfricanAmerican |
1.237560E-01 |
| Caucasian-vs-Asian |
5.380400E-01 |
| AfricanAmerican-vs-Asian |
1.635170E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.25939999999314E-05 |
| Normal-vs-Female |
1.184510E-03 |
| Male-vs-Female |
3.471200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.599010E-04 |
| Normal-vs-Age(41-60Yrs) |
1.624730E-04 |
| Normal-vs-Age(61-80Yrs) |
8.848100E-04 |
| Normal-vs-Age(81-100Yrs) |
1.571840E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.170150E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.191650E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.635200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.556600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.779600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.137200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.553200E-01 |
| Normal-vs-Grade 2 |
2.470200E-02 |
| Normal-vs-Grade 3 |
4.53659999999356E-06 |
| Normal-vs-Grade 4 |
3.17110000036536E-07 |
| Grade 1-vs-Grade 2 |
7.681000E-01 |
| Grade 1-vs-Grade 3 |
1.760030E-01 |
| Grade 1-vs-Grade 4 |
4.224100E-02 |
| Grade 2-vs-Grade 3 |
3.418500E-03 |
| Grade 2-vs-Grade 4 |
3.038300E-04 |
| Grade 3-vs-Grade 4 |
6.927500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.401370E-01 |
| Normal-vs-ccB subtype |
1.65090000003865E-06 |
| ccA subtype-vs-ccB subtype |
4.25310000000678E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.719250E-03 |
| Normal-vs-N1 |
1.984400E-03 |
| N0-vs-N1 |
1.949000E-01 |
|
|
